Skip to main content
Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
232.32
-9.47 (-3.92%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Ligand Pharmaceuticals Revenue

In the year 2025, Ligand Pharmaceuticals had annual revenue of $268.09M with 60.40% growth. Ligand Pharmaceuticals had revenue of $59.67M in the quarter ending December 31, 2025, with 39.37% growth.

Revenue (ttm)
$268.09M
Revenue Growth
+60.40%
P/S Ratio
17.36
Revenue / Employee
$5,703,979
Employees
47
Market Cap
4.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025268.09M100.95M60.40%
Dec 31, 2024167.13M35.82M27.28%
Dec 31, 2023131.31M-64.93M-33.09%
Dec 31, 2022196.25M-45.30M-18.75%
Dec 31, 2021241.54M77.98M47.68%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Legend Biotech 1.03B
Apellis Pharmaceuticals 1.00B
Caris Life Sciences 812.03M
Corcept Therapeutics 761.41M
Amicus Therapeutics 634.21M
TG Therapeutics 616.29M
Xenon Pharmaceuticals 7.50M
CG Oncology 4.04M
Revenue Rankings

LGND News

More News